Scientists hunt for early warning signs of dangerous cancer drug reactions
NCT ID NCT07192315
Summary
This study aims to find biological markers that can predict which cancer patients are likely to experience severe side effects from immunotherapy drugs. Researchers will collect various blood and health data from 160 adults with solid tumors before and after they start standard immunotherapy treatment. The goal is to develop a test that identifies high-risk patients early, allowing doctors to monitor them more closely and potentially prevent dangerous complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assistance Publique Hôpitaux de marseille
Marseille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.